AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

7,837.00p
   
  • Change Today:
    -41.00p
  • 52 Week High: 7,946.00
  • 52 Week Low: 5,325.00
  • Currency: UK Pounds
  • Shares Issued: 1,312.14m
  • Volume: 505,241
  • Market Cap: 102,832m
  • RiskGrade: 93

AstraZeneca Overview

A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

AstraZeneca Financials

Latest F'cast
Div Yield 2.7% 2.7%
Div Cover 1.2 1.3
Op Mrgn 15.3% 23.7%
ROCE 103.5%  
Latest F'cast
P/E 29.4 28.7
PEG n/a 8.3
Pr/Revenue 6.1 5.5
Pr/Book 9.5  
Latest F'cast
Revenue -1.7% -34.9%
PBT -10.5% 71.0%
EPS -19.2% 3.6%
DPS n/a -40.8%

AstraZeneca Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-14 26,095.00 1,246.00 428.00¢ 13.8 n/a -15% 280.00¢ 4.7%
31-Dec-15 24,708.00 3,069.00 426.00¢ 14.1 n/a -0% 280.00¢ 4.7%
31-Dec-16 23,002.00 3,552.00 431.00¢ 13.4 13.4 +1% 280.00¢ 4.9%
31-Dec-17 22,465.00 2,227.00 428.00¢ 15.6 n/a -1% 280.00¢ 4.2%
31-Dec-18 22,090.00 1,993.00 346.00¢ 22.1 n/a -19% 280.00¢ 3.7%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

AstraZeneca Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 18,699.73 4,434.31 275.65p 28.4 7.9 +4% 215.58p 2.7%
31-Dec-20 20,673.55 5,190.02 324.99p 24.1 1.3 +18% 218.06p 2.8%
31-Dec-21 22,890.61 6,470.15 405.01p 19.4 0.8 +25% 222.74p 2.8%

Copyright © 2020 FactSet Research Systems Inc. All rights reserved.

Latest AstraZeneca Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 7,837.00p
Change Today -41.00p
% Change -0.52 %
52 Week High 7,946.00
52 Week Low 5,325.00
Volume 505,241
Shares Issued 1,312.14m
Market Cap 102,832m
RiskGrade 93

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
80.83% below the market average80.83% below the market average80.83% below the market average80.83% below the market average80.83% below the market average
1.75% above the sector average1.75% above the sector average1.75% above the sector average1.75% above the sector average1.75% above the sector average
Price Trend
84.90% above the market average84.90% above the market average84.90% above the market average84.90% above the market average84.90% above the market average
75.44% above the sector average75.44% above the sector average75.44% above the sector average75.44% above the sector average75.44% above the sector average
Income
39.05% below the market average39.05% below the market average39.05% below the market average39.05% below the market average39.05% below the market average
60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average
Growth
93.22% below the market average93.22% below the market average93.22% below the market average93.22% below the market average93.22% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

What The Brokers Say

Strong Buy 20
Buy 0
Neutral 3
Sell 1
Strong Sell 3
Total 27
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 08-Aug-19 28-Feb-19
Paid 09-Sep-19 27-Mar-19
Amount 90.00¢ 190.00¢

Trades for 20-Jan-2020

Time Volume / Share Price
16:35 1,213 @ 7,837.00p
16:35 222,080 @ 7,837.00p
16:29 6 @ 7,826.00p
16:29 218 @ 7,826.00p
16:29 54 @ 7,826.00p

Top of Page